Medication Use. Medication use is expected to fall within the guidelines established for treating COPD [40]. Study participants will be asked to provide information regarding their use of four classes of medications, including bronchodilators (beta-agonists, anticholinergics, methylxanthines), corticosteroids, antibiotics, and anti-inflammatories (e.g. statins, roflumilast). Addition of new medications in these classes or alterations in dose over the course of the study will be tracked. Study participants will be requested to bring all medication containers with them to each follow-up visit.
Appears in 2 contracts
Sources: Clinical Investigational Plan, Clinical Investigational Plan